Clinical Trial Update: Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating oral bicarbonate as an adjuvant for pain reduction in patients with tumor-related pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Tumor, Cancer | Phase 1 | Status: TERMINATED